Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 53Neoplasms 4Neoplasm Metastasis 2Recurrence 1PSA Level Greater Than Two 1Bulbo-Spinal Atrophy, X-Linked 1Breast Neoplasms, Male 1Breast Neoplasms 1

Interventions

enzalutamide 3pembrolizumab 1nilutamide 1bicalutamide 1apalutamide 1Vorinostat 1Tamoxifen 1Panobinostat 1Dasatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Bulbo-Spinal Atrophy, X-Linked × bicalutamide × Clear all
NCT00878436 2018-02-07

Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration

NYU Langone Health

Phase 1/2 Completed
52 enrolled 8 charts
Genitourinary

Prostatic Neoplasms, Bulbo-Spinal Atrophy, X-Linked

Data powered by HemOnc (CC BY 4.0) Colophon âš¡